What's breaking now, across thousands of outlets.
For Akeso CEO Michelle Xia, the intense spotlight on her company and its PD-1xVEGF bispecific ivonescimab still feels new, despite several years in the headlines as one of the industry's most closely watched drug programs. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
[New Zimbabwe] You are awake at 3am again. Your heart is racing, the sheets are damp, and you already know tomorrow will be a fog.
Readily Diagnostics, a Swedish point-of-care diagnostics company, has received a grant of approximately €811k (about 9 million SEK) from the Gates Foundation to develop an affordable test for the…
Two people spend an evening in the same garden and receive roughly the same number of mosquito bites. By morning, one barely notices them—while the other is covered in large, swollen, intensely itchy…
Recurrence is currently generally diagnosed by mammogram, ultrasound, biopsies, scans, or blood tests to detect tumor markers.
BUNIA, Congo (AP) — Parents and teachers at the epicenter of Congo’s fast-moving Ebola outbreak are urging authorities to delay the reopening of schools as infections continue to outpace efforts to…
Mumbai, August 27, 2026: Rajawadi Hospital in Ghatkopar is facing an acute shortage of Resident Medical Officers (RMOs) in its Department of Medicine, with a single doctor reportedly handling 400–500…
